4//SEC Filing
Birchall Jonathan 4
Accession 0001169245-22-000013
CIK 0001169245other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 7:25 PM ET
Size
8.0 KB
Accession
0001169245-22-000013
Insider Transaction Report
Form 4
Birchall Jonathan
Chief Commercial Officer
Transactions
- Award
Restricted Stock Unit
2022-02-24+11,250→ 11,250 total→ Common Stock (11,250 underlying) - Award
Employee Stock Option (right to buy)
2022-02-24+52,500→ 52,500 totalExercise: $1.13Exp: 2022-02-24→ Common Stock (52,500 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit is the economic equivalent of one share of PhaseBio Pharmaceuticals, Inc. common stock and is converted into common stock upon vesting subject to the reporting person's continued service through each such date.
- [F2]These Restricted Stock Units vest in equal one-third amounts on April 1, 2023, 2024, and 2025.
- [F3]The shares subject to the option shall vest in equal monthly installments over 48 months from February 24, 2022, subject to the reporting person's continued service through each such date.
Documents
Issuer
PhaseBio Pharmaceuticals Inc
CIK 0001169245
Entity typeother
Related Parties
1- filerCIK 0001892776
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 7:25 PM ET
- Size
- 8.0 KB